Managing Increased Cancer Risk in Transgender Individuals With HIV Infection

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC with Pharmacotherapy Credit

Credits:

0.75
Improving Transgender Patient Care: Understanding Bias and Addressing Unique Needs

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Resources to Improve the Care of Patients With NSCLC and EGFR Mutations

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Planning Effective and Affirming Preventive Care Plans Consistent With a Patient’s Current Anatomical Structure

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Expert Think Tank: Lung Cancer Experts Discuss Current Standard of Care and Ongoing Challenges in the Care of Patients With EGFR-Mutated NSCLC

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.25
Key Emerging Treatment Strategies for Patients With EGFR-Mutated Advanced NSCLC

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Immune Checkpoint Inhibition in Early-Stage TNBC

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Community Care Team Workshops: New Frontline Strategies Challenge Longtime Standards in DLBCL

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Multidisciplinary Approaches for Evaluating Risk Factors and Preventive Measures for Transgender Individuals

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
The Evolving Management of Relapsed/Refractory Myeloma: Clinical, Economic, and Patient-Centric Strategies for Managed Care Pharmacy Professionals

Content Format:

Multimedia

Credit Type:

ACPE

Credits:

1.50
Gynecologic Cancers: Expert Guidance for Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Advances in Precision Medicine for NSCLC: Expert Guidance for Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Antimicrobial Optimization in the ICU: Treating HABP/VABP in the Critically Ill Patient

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Germline BRCA Testing and Targeting With Adjuvant Olaparib in HER2- EBC

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Risk Assessment and Ki-67 Testing in HR-Positive/HER2-Negative EBC for Adjuvant Abemaciclib

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Targeting LAG-3 to Potentiate Antitumor Immune Activity: Expert Guidance on Molecular Function and Clinical Application

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Key Studies in Leukemias: Independent Conference Coverage of ASH 2021

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Mastering the Evolving Treatment Landscape in HER2-Positive Breast Cancer: Current Guidance and Future Perspectives

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Practical Guidance on Individualized Patient Care Strategies for Myelodysplastic Syndromes

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Expert Guidance on Treatment Advances in Acute Myeloid Leukemia

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Antibody–Drug Conjugates in Lung Cancer Care

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Chronic Lymphocytic Leukemia: Applying the Latest Data in Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Changing the Course of Outcomes in NSCLC: Immunotherapy Approaches for Early-Stage Disease

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Surgeon Perspective

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
What to Know About the New Approval for Abemaciclib in Patients With Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Individualizing Cervical Cancer Care With Current and Emerging Practice-Changing Clinical Data for Cervical Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Mechanisms of Resistance to EGFR TKI Therapy in Advanced Lung Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Treatment for EGFR-Mutant Lung Cancer After Progression on EGFR TKI

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Acknowledging Patient Preferences (Goals) and Promoting Enrollment on Clinical Trials for Cervical Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Improving Provider Awareness About Healthcare Equity: Improving Access to Care for Women With Cervical Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Risk Factors, Screening, and Molecular Testing in Cervical Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Cancer Conversations™ Application of Individualized Treatment for MDS: Expert Guidance for Clinical Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Role of HER3 in Lung Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Updates on the Management of Patients With Lymphomas During the COVID-19 Pandemic

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Individualizing Ovarian Cancer Care With Current and Emerging Practice-Changing Clinical Data

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Acknowledging Patient Preferences (Goals) and Promoting Enrollment on Clinical Trials for Patients With Ovarian Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Risk Factors, Screening, and Molecular Testing in Ovarian Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: A Pharmacist’s Perspective

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Improving Provider Awareness About Healthcare Equity: Improving All Patients’ Access to Care in Ovarian Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Acknowledging Patient Preferences (Goals) and Promoting Enrollment on Clinical Trials for Endometrial Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Understanding the Evolving Immuno-Oncology Treatment Paradigm in Non-Small-Cell Lung Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Individualizing Endometrial Cancer Care With Current and Emerging Practice-Changing Clinical Data

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Optimizing the Use of BTK Inhibitors in B-Cell Malignancies: Addressing BTK Inhibitor Toxicities

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Risk Factors, Molecular Testing and Screening in Endometrial Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Improving Provider Awareness About Healthcare Equity: Improving Endometrial Cancer Patients’ Access To Care

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Key Studies in Genitourinary Cancers: CCO Independent Conference Highlights of the 2021 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Immune Checkpoint Inhibitor–Based Therapy for Early-Stage Lung Cancer: Medical Oncology Perspective

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Key Studies in NSCLC: Independent Conference Coverage of the 2021 ASCO Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Key Studies in Breast and Gynecologic Cancers: Independent Conference Coverage of the 2021 ASCO Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
Advances in Prophylaxis and Treatment of Acute and Chronic GVHD: Expert Guidance and Practical Considerations

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.00
Managing Serious Adverse Events Associated with BTK Inhibitor Treatment

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.25
Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 1: Drug–Drug and Drug–Food Interactions

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.25
Strategies for Avoiding Adverse Reactions to BTK Inhibitor Therapy, Part 2: Patient Strategies for Self-Management

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.25
BTK Inhibitors in CLL and Lymphomas: Overview and Current Indications

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.25
Adverse Events Associated with BTK Inhibitor Treatment

Content Format:

Podcast Episodes

Credit Type:

AAPA | ANCC

Credits:

0.25
Medical Minute: Recently Approved HER2 and TROP2 Agents: Pharmacist Considerations

Content Format:

Multimedia

Credit Type:

ABIM MOC | ACPE | AMA | ANCC

Credits:

0.25
Clinical Decision-Making for Patients With HR+ HER2- Early Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Staying on TRK: Addressing Clinical Challenges and Improving Outcomes in NTRK Fusion Positive Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Medical Minute: Recent Advances in HER2-, HER3-, and TROP2-Targeted Therapies for Metastatic Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
Immunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.50
Immunotherapy Approaches for HCC

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
CAR T-Cell Therapy: Optimizing Collaboration, Referral, Treatment, and Follow-up to Improve Outcomes

Content Format:

Case Challenge

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Managing Immune-Related Adverse Events: A Nursing Perspective

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Dosing, Administration, and Risks/Benefits of Treatment Strategies for UC: A Patient’s Perspective

Content Format:

Multimedia

Credit Type:

--

Credits:

--
MedicalMinute: Identifying and Managing CAR T-Cell–Mediated Toxicities

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
MedicalMinute: Supportive Care Considerations for CAR T-Cell Therapy: Establishing Standards of Care With the Multidisciplinary Team

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
MedicalMinute: Guiding Patients and Caregivers Starting CAR T-Cell Therapy

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
MedicalMinute: Recent Advances in Targeting HER2 and HER3 in Metastatic Gastrointestinal Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.50
MedicalMinute: Current and Near-Future CAR T-Cell Therapy Indications

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Mastering Current Management of CLL

Content Format:

Multimedia

Credit Type:

ACPE

Credits:

1.00
MedicalMinute: Emerging Guidance on COVID-19 Vaccination in Patients Receiving Immune Checkpoint Inhibitors

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Transforming Modern Care in NSCLC: Navigating Advances in New and Emerging Biomarkers to Guide Precision Treatment Decisions

Content Format:

Multimedia

Credit Type:

ABPath MOC | AMA

Credits:

1.50
Navigating an Increasingly Complex Framework to Improve Patient Outcomes With ICI-Based Therapy

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.25
Biomarker-Driven Therapy for NSCLC: Experts Discuss Current and Future Trends

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
Immunotherapy for Advanced HCC: Case Series

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.50
Planning Therapy for High-Risk HER2-Positive Early-Stage Breast Cancer: Expert Viewpoint

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
MedicalMinute: Recent Advances With Antibody–Drug Conjugates Targeting HER2, HER3, and TROP2 in Lung Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
Selecting First-line Therapy for Advanced UC: Chemotherapy vs Immunotherapy

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Treatment-Refractory Advanced Urothelial Cancer: What to Do After Chemotherapy and/or Immunotherapy

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Emerging Role for Immunotherapy in Localized Bladder Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Individualized Patient Care: Role of Biomarkers in Urothelial Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Workshops With Experts: Advances to Improve Clinical Outcomes for Veterans With Pancreatic Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Smarter. Stronger. Together: Educating Providers and Patients to Optimize the Use of Targeted Oral Therapies for HR+/HER2- Breast Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Multidisciplinary Perspectives Informing Optimal Treatment of RET-Altered Lung and Thyroid Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Cancer Conversations™: Experts Discuss and Debate Optimal Treatment of Relapsed/Refractory Multiple Myeloma

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
Key Studies in Lung Cancer: Independent Conference Coverage of the World Conference on Lung Cancer 2020

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.50
Key Studies in Urothelial, Prostate, and Kidney Cancer: CCO Independent Conference Highlights of the 2021 Genitourinary Cancers Symposium

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Medical Minute: Treatment Algorithms for Melanoma

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
New Targeted Therapies and the Evolution of Urothelial Carcinoma Care

Content Format:

Multimedia

Credit Type:

--

Credits:

--
MedicalMinute: What to Expect When Your Patient Is Starting Immune Checkpoint Inhibitor–Based Therapy

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
MedicalMinute: A Practical Guide to Managing Common Immune-Related Adverse Events

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
MedicalMinute: A Practical Guide to Managing Less Common Immune-Related Adverse Events

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Key Studies in Myeloma: CCO Independent Conference Highlights of the 2020 Virtual ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.50
The Role of the Immune System and Immune Escape in Head and Neck Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Predictive Biomarkers for Immunotherapy in HNSCC

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Medical Minute: Emerging Therapies and Novel Combinations for Melanoma Treatment

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
The Importance of Molecular Testing in Head and Neck Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Medical Minute: Biomarker-Driven Treatment Selection in Melanoma

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Current and Emerging Clinical Strategies for Pancreatic Cancer Treatment

Content Format:

Multimedia

Credit Type:

--

Credits:

--
CCO Independent Conference Highlights of the Virtual 2021 Gastrointestinal (GI) Cancers Symposium

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Strategies for Managing Immune-Related Adverse Events in Patients With Head and Neck Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
The Emerging Role of PARP Inhibitors in the Maintenance Setting for Patients With Advanced Pancreatic Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Medical Minute: Patient-Centered Communication in Melanoma—Empowering Patients to Be Advocates in Their Care

Content Format:

Case Challenge

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Neoadjuvant and Adjuvant Therapy Strategies for Patients With Resectable Pancreatic Cancer

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Key Studies in Lymphomas: CCO Independent Conference Highlights of the 2020 Virtual ASH Annual Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
New Insights in Breast Cancer: Independent Conference Coverage of SABCS 2020

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.25
Current Therapeutic Options for Metastatic Pancreatic Cancer: Second-line Treatment

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Current Therapeutic Options for Metastatic Pancreatic Cancer: First-line Treatment

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Key Studies in Myelodysplastic Syndromes and Myeloproliferative Neoplasms: CCO Independent Conference Highlights of the 2020 Virtual ASH Annual Meeting

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Key Studies in Leukemias: Independent Conference Coverage of ASH 2020

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.25
Managing Immune-Related Adverse Events in Head and Neck Cancer

Content Format:

Case Challenge

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
RET-Driven NSCLC and Thyroid Cancer: Expert Guidance for Improving Outcomes

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Key Studies in Nonmalignant Hematology: Independent Conference Coverage of ASH 2020

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Case Discussion: Relapsed ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Case Discussion: Management of Immune-Related AEs

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Role of Radiation Therapy in the Management of ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Key Clinical Trials of Immunotherapy in SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Critical Advances in Systemic Therapy for HCC: Building on Recent Progress for Community Practices

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.75
Expert Guidance and Resources to Personalize Care and Improve Outcomes for Patients With RCC

Content Format:

Text Module

Credit Type:

--

Credits:

--
Evolving Treatment Options for Thrombocytopenic Patients With MDS

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
An Expert Overview of Immunotherapy for Advanced HCC

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.25
How I Treat Anemia in MDS

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Management of Higher-Risk MDS

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
The New Biomarkers Pathologists Need to Know for Precision Therapy in Lung Cancer

Content Format:

Video

Credit Type:

ABPath MOC | AMA

Credits:

1.00
Novel Therapies for Lower-Risk MDS

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
MedicalMinute: Assessment of HER2 Status and Targeting HER2 and HER3 in Gastrointestinal Cancers

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
Management Options for NTRK Fusion-positive Patients With Head and Neck Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Managing AEs With Enfortumab Vedotin: A Patient Case Example

Content Format:

Case Challenge

Credit Type:

--

Credits:

--
Rationale for Targeting NTRK Fusions in Head and Neck Cancers

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
NTRK Fusions: Who To Test? When To Test?

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Managing AEs With Erdafitinib: A Patient Case Example

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Exploring Future Roles for Immune-Oncology in Head and Neck Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Honing Treatment Strategies in Advanced Prostate Cancer: Latest Evidence to Guide Clinical Practice

Content Format:

Video

Credit Type:

AANP | ACPE | AMA

Credits:

1.00
Current and Future Considerations for the Use of Checkpoint Inhibitors in Gastroesophageal Cancers

Content Format:

Video

Credit Type:

AMA

Credits:

0.75
An Overview of HER2, HER3, and TROP2 Testing and Targeted Treatment in Breast and GI Cancers

Content Format:

Multimedia

Credit Type:

ABPath MOC | AMA

Credits:

0.75
Understanding the Therapeutic Antibody–Drug Conjugate Enfortumab Vedotin

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Immunotherapy for Advanced HCC: Experts Answer Clinician Questions

Content Format:

Podcast Episodes

Credit Type:

AMA

Credits:

0.25
MedicalMinute: Expert Answers to Key Questions in HER2 Testing in Metastatic Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
MedicalMinute: Coordinating Care in the Community Setting to Improve Adherence to HER2 Testing Recommendations for MBC

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
Transforming the Treatment Paradigm for Patients With MDS: Webcast

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
Case Discussion: Newly Diagnosed ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Advances in GVHD: Current Treatments, Optimizing Prophylaxis, and Integrating Novel Therapies

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Hemophilia A Without Inhibitors: Personalizing Therapy With Factor VIII Prophylaxis: Webcast

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Rationale for Using Immunotherapy in the Treatment of ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Overview of Immunotherapy Options for Treatment-Naive ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Overview of Therapeutic Options for Relapsed ES-SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Understanding the FGFR-Targeted Therapy Erdafitinib

Content Format:

Multimedia

Credit Type:

--

Credits:

--
The New Biomarkers Clinicians Need to Know for Precision Therapy in Lung Cancer

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Management of Limited-Stage SCLC

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Therapeutic Strategies for Pretreated Metastatic UC: A Nursing Perspective

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Immunotherapy for HCC: Current Evidence and Future Directions

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Practical Guidance on Optimizing Management of Follicular Lymphoma

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.25
Advances to Improve Clinical Outcomes and Quality of Life for Veterans With Multiple Myeloma

Content Format:

Video

Credit Type:

--

Credits:

--
Therapeutic Strategies for Pretreated Metastatic UC: A Pharmacy Perspective

Content Format:

Multimedia

Credit Type:

--

Credits:

--
How I Manage Patients With NTRK Fusion–Positive Head and Neck Cancer

Content Format:

Case Challenge

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
The Current Treatment Landscape in Head and Neck Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Frontline Immune Checkpoint Inhibitor Therapy in Advanced Head and Neck Cancer

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
MedicalMinute: Selecting Novel HER2- and TROP2-Targeted Therapeutics for Patients With Metastatic Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.25
Immuno-Oncology Combinations in Advanced RCC: Building on Recent Progress

Content Format:

Case Challenge

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Assessment of HER2 Status and Targeting HER2 in Gastrointestinal Cancers

Content Format:

Video

Credit Type:

ABPath MOC | AMA

Credits:

0.75
Recent and Emerging Therapies for Follicular Lymphoma

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Applying The Results of Practice-Changing Clinical Research To Patient Care in Hepatocellular Carcinoma

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Cases in CLL: Third-line Treatment Following BTK Inhibitor– and Venetoclax-Based Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Options for an Older Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
The Evolution of Immunotherapy in Head and Neck Cancer

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Optimizing Multiple Myeloma Care: Expert Guidance for the Practicing Clinician

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
NSCLC Biomarkers: Current Landscape and Future Perspectives for Precision Medicine

Content Format:

Video

Credit Type:

--

Credits:

--
Cases in CLL: Patient Progressing on BR With Subsequent Ibrutinib Intolerance

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Targeting HER2, HER3 and TROP2 in Breast Cancer

Content Format:

Video

Credit Type:

ABPath MOC | AMA

Credits:

0.75
Cases in CLL: High-Risk Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Fit, Younger Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL: Second-Line Therapy Following Chemoimmunotherapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Key Studies in Lung Cancer: Independent Conference Coverage of the ASCO 2020 Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
Critical Advances in CLL: Building on Recent Progress for Community Practices

Content Format:

Case Challenge

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Hematologic Malignancies: A Review of Key Clinical Studies

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.25
Clinical Considerations for RET Fusion–Positive NSCLC

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Diagnostic Testing for HER2, HER3, and TROP2 and Treatment Implications in Metastatic Breast Cancer

Content Format:

Video

Credit Type:

ABPath MOC | AMA

Credits:

1.25
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Key Studies in Genitourinary Cancers: Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Advances in the Treatment of Pancreatic Cancer: Nursing Education to Optimize Clinical Practice

Content Format:

Video

Credit Type:

--

Credits:

--
Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
CAR T-Cell Therapy: Applying the Data, Tailoring Treatment, and Future Considerations

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Precision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
The Evolving Therapeutic Landscape for HER2-Positive Early-Stage Breast Cancer

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Key Studies in Gastrointestinal Cancers: Independent Conference Coverage of the 2020 ASCO Virtual Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
My Thoughts on the Future of FLT3 Therapy in AML

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.25
An Overview of Biomarkers Essential for Precision Therapy in Lung Cancer

Content Format:

Video

Credit Type:

ABPath MOC | AMA

Credits:

1.00
How We Are Managing Outpatient Head and Neck Cancer Care During the COVID-19 Pandemic

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Caring for Patients Treated With Immune Checkpoint Inhibitors: Guidance and Resources for Nurses and Pharmacists

Content Format:

Video

Credit Type:

ACPE | ANCC

Credits:

1.00
Current and Future Therapeutic Strategies for Multiple Myeloma

Content Format:

Video

Credit Type:

--

Credits:

--
Expert View on the Evolving Treatment Paradigm in Advanced NSCLC

Content Format:

Text Module

Credit Type:

--

Credits:

--
How We Use BTK Inhibitors to Treat CLL, MCL, MZL, and Waldenström Macroglobulinemia

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Expert Perspectives on Integrating Immuno-Oncology Therapeutics Into the Management of Metastatic Triple-Negative Breast Cancer

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Expert Guidance on Therapeutic Strategies for Multiple Myeloma

Content Format:

Text Module

Credit Type:

--

Credits:

--
Expert Guidance on the Expanding Role of Immunotherapy in HNSCC

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.50
Incorporating Recent Advances in the Treatment of MPNs Into Clinical Practice

Content Format:

Video

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Integrating Oncology Treatment Biosimilars Into Clinical Practice

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Expert Guidance on Optimizing Treatment Strategies for Acute Lymphoblastic Leukemia

Content Format:

Text Module

Credit Type:

--

Credits:

--
Graft-vs-Host Disease Management in the Modern Era: Expert Insights on Incorporating Recent Advances Into Care

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
HER2-Positive Metastatic Breast Cancer: Current Status and Promising Agents

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
How to Identify and Optimize “Real-World” Patients for CAR T-Cell Therapy

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
New Insights in Breast Cancer: Independent Conference Coverage of SABCS 2019

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
The Pharmacist’s Role in Managing CAR T-Cell–Associated Toxicities

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Expert View on Managing Patients With CLL Using Targeted Therapies

Content Format:

Multimedia

Credit Type:

--

Credits:

--
My Take on Key Studies in CAR T-Cell Therapy From ASH 2019

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Immunotherapy for Advanced NSCLC: Discussing Goals and Treatments With Your Health Care Providers

Content Format:

Multimedia

Credit Type:

--

Credits:

--
Leveraging Evolving Data to Inform Treatment in HR-Positive, HER2-Negative Advanced Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
Incorporating the Latest Therapeutic Strategies for HCC: Collaborating to Optimize Patient Outcomes

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
A Look Ahead to the 2019 SABCS Meeting

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.25
Advances in Predictive Biomarkers for Immune Checkpoint Inhibitors in Lung Cancer: Why, Who, and How

Content Format:

Multimedia

Credit Type:

ABPath MOC | AMA

Credits:

1.00
Leveraging CAR T-Cell Combinations to Overcome Nonresponse and Relapse

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Educating Patients and Caregivers About CAR T-Cell Therapies: A Nursing Perspective

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
What’s New With CAR T-Cell Therapies for Relapsed/Refractory Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
A New Era of Immunotherapy in Small-Cell Lung Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

0.50
Experts Discuss Clinical Application of TRK Inhibitors and Tumor Agnostic NTRK Fusion Testing

Content Format:

Multimedia

Credit Type:

--

Credits:

--
The Biomarkers Oncologists Need to Know for Personalized Cancer Care in 2019

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
An Evening With Experts: Selecting and Sequencing Therapy in HR+/HER2- Metastatic Breast Cancer

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00